Skip to main content
SpringerLink
Log in

Herpes Simplex Virus Infections

  • Chapter
  • First Online:
Sexually Transmitted Infections in HIV-Infected Adults and Special Populations

  • 665 Accesses

Abstract

Genital herpes is the most prevalent cause of genital ulcer disease in the world and is commonly encountered in the HIV primary care setting. While most herpes simplex virus (HSV) infections are asymptomatic, HIV-infected individuals are more likely to present with atypical and severe manifestations of this common infection. This chapter will discuss the natural history, evaluation, management, and prevention of genital HSV infections as well as discuss useful counseling strategies for providers to utilize with their patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Schiffer JT, Corey L. Herpes simplex virus-2 infection: new understandings in the dynamics of viral-host interactions and their implications for developing novel antivirals, vaccines and immunotherapies. Nat Med. 2013;19:280–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Koelle DM, Corey L. Herpes simplex: insights on pathogenesis and possible vaccines. Annu Rev Med. 2008;59:381–95.

    Article  CAS  PubMed  Google Scholar 

  3. McClelland RS, Wang CC, Overbaugh J, Richardson BA, Corey L, Ashley RL, et al. Association between cervical shedding of herpes simplex virus and HIV-1. AIDS. 2002;16(18):2425–30.

    Article  PubMed  Google Scholar 

  4. Posavad CM, Wald A, Kuntz S, Huang ML, Selke S, Krantz E, et al. Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy. J Infect Dis. 2004;190(4):693–6.

    Article  PubMed  Google Scholar 

  5. Sobngwi-Tambekou J, Taljaard D, Lissouba P, Zarca K, Puren A, Lagarde E, et al. Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis. 2009;199(7):958–64.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Glynn JR, Carael M, Auvert B, Kahindo M, Chege J, Musonda R, et al. Why do young women have a much higher prevalence of HIV than young men? A study in Kisumu, Kenya and Ndola, Zambia. AIDS. 2001; (Suppl 4):S51–60.

    Google Scholar 

  7. Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr. 2004;35(5):435–45.

    Article  PubMed  Google Scholar 

  8. Barrnabas RV, Celum C. Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions. Curr HIV Res. 2012; 10:228–37.

    Google Scholar 

  9. Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex type 2 infections. Bull World Health Organ. 2008;86(10):805–12.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes. 2004;11(Suppl 1):24A–35A.

    PubMed  Google Scholar 

  11. Centers for Disease Control and Prevention (CDC). Seroprevalence of herpes simplex virus type 2 among persons aged 14–49 Years. United States, 2005–2008. Morbidity and Mortality Weekly Report. 2010; 59(15):456–9.

    Google Scholar 

  12. Curr HIV Research, Weiss IHMF, Bohl DD, Katz KA, Bernstein K, et al. Prevalence and correlates of herpes simplex virus type-2 infection among men who have sex with men, San Francisco, 2008. Sex Transm Dis. 2011; 38(7):617–21.

    Google Scholar 

  13. McQuillan GM, Kruszon-Moran D, Granade T, Feldman JW. Seroprevalence of human immunodeficiency virus in the US household population aged 18–49 years: the national health and nutrition examination survey, 1999–2006. J Acquir Immune Defic Syndr. 2009 Aug 25.

    Google Scholar 

  14. Gnann JW Jr, Whitley RJ. Clinical practice, genital herpes. N Engl J Med. 2016;375(7):666–74.

    Article  PubMed  Google Scholar 

  15. Engelberg R, Carrell D, Krantz E, Corey L, Wald A. Natural history of genital herpes simplex virus type 1 infection. Sex Transm Dis. 2003;30:174–7.

    Article  PubMed  Google Scholar 

  16. Tronstein E, Johnston C, Huang ML, Selke S, Magaret A, Warren T, et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA. 2011;305:1441–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Tobian AA, Grabowski MK, Serwadda D, Newell K, Ssebbowa P, Franco V, et al. Reactivation of herpes simplex virus type-2 after initiation of antiretroviral therapy. J Infect Dis. 2013;208:839–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Siegal FP, Lopez C, Hammer GS, Brown AE, Kornfeld SJ, Gold J, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med. 1981;305:1439–44.

    Article  CAS  PubMed  Google Scholar 

  19. Norris SA, Kessler HA, Fife KH. Severe, progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS. J Infect Dis. 1988;157:209–10.

    Article  CAS  PubMed  Google Scholar 

  20. Safrin S, Ashley R, Houlihan C, Cusick PS, Mills J. Clinical and serologic features of herpes simplex virus infection in patients with AIDS. AIDS. 1991;5:1107–10.

    Article  CAS  PubMed  Google Scholar 

  21. Sbidian E, Battistella M, LeGoff J, Lafaurie M, Bézier M, Agbalika F, et al. Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltratio and immunomodulators as effective therapeutic strategy. Clin Infect Dis. 2013;57:1648–55.

    Article  CAS  PubMed  Google Scholar 

  22. Vogel P, Smith KJ, Skeleton HG, Cuozzo D, Wagner KF. Verrucous lesions of herpes simplex in HIV-1+ patients. Military medical consortium for the advancement of retroviral research. Int J Dermatol. 1993;32:680–2.

    Article  CAS  PubMed  Google Scholar 

  23. Tong P, Mutasim DF. Herpes simplex virus infection masquerading as condyloma acuminata in a patient with HIV disease. Br J Dermatol. 1996;134:797–800.

    Article  CAS  PubMed  Google Scholar 

  24. Di Lucca-Christment J, Jacobelli S, Gressier L, Plantier F, Laude H, Rozenberg F, et al. Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment. AIDS. 2012;26:523–6.

    Article  PubMed  Google Scholar 

  25. Ashley RL, Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev. 1999;12:1–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64(RR-03):1–137.

    Google Scholar 

  27. Reyes M, Shail NS, Graber JM, Nisenbaum R, Wetherall NT, Fukuda K, et al. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency clinics. Arch Intern Med. 2003;163:76–80.

    Article  PubMed  Google Scholar 

  28. Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J, et al. The AIDS clinical trials group. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N Engl J Med. 1991;325:551–5.

    Article  CAS  PubMed  Google Scholar 

  29. Perkins N, Nisbet M, Thomas M. Topical imiquimod treatment of acyclovir-resistant herpes simplex disease: case series and literature review. Sex Transm Infect. 2011;87:292–5.

    Google Scholar 

  30. McElhiney LF. Topical cidofovir for the treatment of resistant viral infections. Int J Pharm Compd. 2006;10:324–8.

    Google Scholar 

  31. Wald A, Langenberg AG, Krantz E, Douglas JM Jr, Handsfield HH, DiCarlo RP, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med. 2005;143:707–13.

    Article  PubMed  Google Scholar 

  32. Magaret AS, Mujugira A, Hughes JP, Lingappa J, Bukusi EA, DeBruyn G, et al. Condom use and per-act HSV-2 transmission. Clin Infect Dis. 2016;62:456–61.

    PubMed  Google Scholar 

  33. Mujugira A, Magaret AS, Celum C, Baeten JM, Lingappa JR, Morrow RA, et al. Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial. J Infect Dis. 2013;208:1366–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Johnston C, Koelle DM, Wald A. Current status and prospects for development of an HSV vaccine. Vaccine. 2014;32:1553–60.

    Article  CAS  PubMed  Google Scholar 

  35. Abdool Karim SS, Abdool Karim Q, Kharsany AB, Baxter C, Grobler AC, Werner L, et al. CAPRISA 004 trial group. Tenofovir gel for the prevention of herpes simplex virus type 2 infection. N Engl J Med. 2015;373:530–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Additional Resources

  1. Ashley RL, Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev. 1999; 12:1–8. Excellent overview of the HSV epidemic and utility of type-specific serology for diagnosis and counseling of genital herpes.

    Google Scholar 

  2. Wald A. New therapies and prevention strategies for genital herpes. Clin Infect Dis. 1999; 28(suppl 1): S4–S13. Summary for approach to treatment of disease.

    Google Scholar 

  3. Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006; 55(RR-11): 1–94. The latest and best expert guidance for treatment of genital herpes.

    Google Scholar 

  4. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, et al. Once-daily valacyclovir to reduce the risk of genital herpes. N Engl J Med. 2004; 350:11–20. This article provides the pivotal data on the benefit of suppressive therapy to reduce the transmission risk of genital HSV-2.

    Google Scholar 

  5. Xu F, Sternberg MR, Kottri BJ, McQuillan GM, Lee FK, Nahmias AJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006; 296(8): 964–973. State of the art data describing HSV-1 and 2 prevalence in the U.S.

    Google Scholar 

  6. Ebel C., Wald A. Managing herpes: how to live and love with a chronic STD. Research Triangle Park, NC: American Social Health Association; 2002. One of the best overviews of genital herpes for patients. Provides important insights on impact of diagnosis on patients and gives clear guidance for counseling.

    Google Scholar 

  7. Handsfield HH. Genital Herpes. New York: McGraw-Hill; 2001. A “one-stop” resource for clinicians and patients.

    Google Scholar 

Internet Resources

  1. American Social Health Association www.ashastd.org ASHA National Herpes Hotline: (919) 361–8488.

  2. American College of Obstetricians and Gynecologist www.accog.com.

  3. CDC Division of Sexually Transmitted Diseases www.cdc.gov/std.

  4. CDC National STD Hotline: English: 800-227-8922, (800) 342-2437 Spanish: (800) 344–7432 www.webMD.com.

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, 130 Mason Farm Road, CB7030, Chapel Hill, NC, 27599-7030, USA

    Peter A. Leone

Authors
  1. Peter A. Leone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter A. Leone .

Editor information

Editors and Affiliations

  1. Division of Infectious Diseases, Wake Forest University Health Sciences, Winston-Salem, North Carolina, USA

    Laura Hinkle Bachmann

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Leone, P.A. (2017). Herpes Simplex Virus Infections. In: Bachmann, L. (eds) Sexually Transmitted Infections in HIV-Infected Adults and Special Populations. Springer, Cham. https://doi.org/10.1007/978-3-319-56694-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56694-8_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56692-4

  • Online ISBN: 978-3-319-56694-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation